Page 12 - Pay Smart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Legalese and wording of the specific justification that gave the nsa access to that data. And from the companys side, i think that theyre starting to realize that they might have thought that data was not, you know, very big in terms of privacy violations but, in the context of collecting all that data from different companies, pro providers, nsa can build a really good profile on people. Melissa charlie you have a keen nose for bs. Do you have a smell of bs at this meeting. These are all his supporters. Melissa thats a great point. Eric schmidt is great obama supporter. Zuckerberg holds fundr...

That navy yard. Susan mcginnis is in washington where investigators are trying to learn more about the shooting. Reporter authorities are focused on one gunman. Were learning more about his past and about a history of Mental Illness that includes hearing voices. The investigation into mondays deadly shooting on a navy base continued through the night. One question that remains unanswered is why. We dont know what the motive is at this stage. Police say 34yearold aaron alexis opened fire inside a building on washingtons navy yard. It was like pow, pow, pow. From his position, he had a snipers v...

Quadrupling after an experimental drug blocks the return of Breast Cancer in women. Blue chip records, the s p 500 fyl out a small gai 300 , thats quadruple. Another big gainer saw shares climb 11 on surging sales of its ms treatment. Meg terrell has more on this big day in biotech, what is behind the numbers at puma and bio again and what investors can look forward to. Reporter stocks are known for versatility, big risk, big reward. Puma soared on the drug for Breast Cancer. In a trial of more than 2,000 patients the medicine helps people live for 33 longer without disease professing. The dru...

Experimental drug blocks the return of Breast Cancer in women. Blue chip records, the s p 500 fyl out a small gai 300 , thats quadruple. Another big gainer saw shares climb 11 on surging sales of its ms treatment. Meg terrell has more on this big day in biotech, what is behind the numbers at puma and bio again and what investors can look forward to. Reporter stocks are known for versatility, big risk, big reward. Puma soared on the drug for Breast Cancer. In a trial of more than 2,000 patients the medicine helps people live for 33 longer without disease professing. The drug was tested for a sp...

Experimental drug blocks the return of Breast Cancer in women. Blue chip records, the s p 500 fyl out a small gai 300 , thats quadruple. Another big gainer saw shares climb 11 on surging sales of its ms treatment. Meg terrell has more on this big day in biotech, what is behind the numbers at puma and bio again and what investors can look forward to. Reporter stocks are known for versatility, big risk, big reward. Puma soared on the drug for Breast Cancer. In a trial of more than 2,000 patients the medicine helps people live for 33 longer without disease professing. The drug was tested for a sp...